Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Equasens (GB:0R9T)
LSE:0R9T
Holding GB:0R9T?
Track your performance easily
0R9T Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€40.65 - €67.00
Previous Close€40.65
Volume21.00
Average Volume (3M)205.00
Market Cap
€611.33M
Enterprise Value€610.65M
Total Cash (Recent Filing)€79.54M
Total Debt (Recent Filing)€72.11M
Price to Earnings (P/E)14.5
Beta0.69
Next Earnings
Mar 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 02, 2024Dividend Yield3%
Share Statistics
EPS (TTM)2.81
Shares Outstanding15,007,208
10 Day Avg. Volume188
30 Day Avg. Volume205
Standard Deviation0.10
R-Squared0.12
Alpha-0.00051
Financial Highlights & Ratios
Price to Book (P/B)6.40
Price to Sales (P/S)5.38
Price to Cash Flow (P/CF)21.50
P/FCF Ratio75.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€75.00Price Target Upside84.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Equasens News
Bulls Say, Bears Say
Bulls Say
Financial GrowthEarnings meetings reinforced confidence in a rebound and company guidance for double-digit organic growth, driven by new hardware sales and product launches across multiple countries.
Market ExpansionEquasens is experiencing a significant change in momentum driven by an improving end-market and continued expansion in Europe.
New Product LaunchesThe company is poised for growth with new product launches, including the planned introduction of a digital healthcare card in France.
Bears Say
EarningsEquasens missed on Q3 expectations, with Q3 coming in 7% lower than management guidance.
Financial PerformanceThe weaker Q3 revenue should result in weaker-than-anticipated profitability in H2.
Profitability OutlookProfitability unlikely to return to its normal level before 1H25.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.15% Mutual Funds
― Other Institutional Investors
97.34% Public Companies and
Individual Investors
0R9T FAQ
What was Equasens’s price range in the past 12 months?
Equasens lowest share price was €40.65 and its highest was €67.00 in the past 12 months.
What is Equasens’s market cap?
Currently, no data Available
When is Equasens’s upcoming earnings report date?
Equasens’s upcoming earnings report date is Mar 28, 2025 which is in 126 days.
How were Equasens’s earnings last quarter?
Equasens released its earnings results on Sep 27, 2024. The company reported €1.143 earnings per share for the quarter, beating the consensus estimate of N/A by €1.143.
Is Equasens overvalued?
According to Wall Street analysts Equasens’s price is currently Undervalued.
Does Equasens pay dividends?
Equasens pays a Annually dividend of €1.25 which represents an annual dividend yield of 3%. See more information on Equasens dividends here
What is Equasens’s EPS estimate?
Equasens’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Equasens have?
Equasens has 15,174,125 shares outstanding.
What happened to Equasens’s price movement after its last earnings report?
Equasens reported an EPS of €1.143 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.344%.
Which hedge fund is a major shareholder of Equasens?
Currently, no hedge funds are holding shares in GB:0R9T
---
Equasens Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.26%
12-Months-Change
Fundamentals
Return on Equity
20.74%
Trailing 12-Months
Asset Growth
6.63%
Trailing 12-Months
Company Description
Equasens
Pharmagest Interactive provides information technology (IT) solutions for pharmacies and the pharmaceutical industry. The company primarily operates through the Solutions for Pharmacy Division, e-Health Division, Health and Social care facilities Division, and Fintech Division. In addition, the company is engaged in the provision of maintenance services, as well as in the e-business business activity of the group is functioned through the various region of France and it derives revenue from Hardware sales, Software sales and Maintenance services.
---
0R9T Stock 12 Month Forecast
Average Price Target
€75.00
▲(84.50% Upside)
Technical Analysis
Best Analysts Covering 0R9T
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-18.75%
reiterated a buy rating 15 days ago
Copying David Vignon's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.75% per trade.
---